Thrivent Financial For Lutherans Corcept Therapeutics Inc Transaction History

Thrivent Financial For Lutherans

  • $45.7 Billion
  • Q2 2025

A detailed history of Thrivent Financial For Lutherans transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Thrivent Financial For Lutherans holds 69,399 shares of CORT stock, worth $5.52 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
69,399
Previous 68,494 1.32%
Holding current value
$5.52 Million
Previous $7.82 Million 34.88%
% of portfolio
0.01%
Previous 0.02%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 26, 2025
BUY
$62.24 - $91.93 $56,327 - $83,196
905 Added 1.32%
69,399 $5.09 Million
Q1 2025

Aug 26, 2025
BUY
$49.85 - $114.22 $3.41 Million - $7.82 Million
68,494 New
68,494 $7.82 Million
Q4 2024

Feb 10, 2025
SELL
$44.66 - $60.85 $42,560 - $57,990
-953 Reduced 1.3%
72,077 $3.63 Million
Q3 2024

Nov 07, 2024
SELL
$29.51 - $46.26 $89,326 - $140,029
-3,027 Reduced 3.98%
73,030 $3.38 Million
Q2 2024

Aug 13, 2024
SELL
$22.21 - $34.48 $58,567 - $90,923
-2,637 Reduced 3.35%
76,057 $2.47 Million
Q1 2024

May 14, 2024
SELL
$21.1 - $27.46 $36,249 - $47,176
-1,718 Reduced 2.14%
78,694 $1.98 Million
Q4 2023

Feb 14, 2024
SELL
$24.82 - $32.88 $53,139 - $70,396
-2,141 Reduced 2.59%
80,412 $2.61 Million
Q3 2023

Nov 14, 2023
SELL
$21.97 - $33.8 $86,342 - $132,834
-3,930 Reduced 4.54%
82,553 $2.25 Million
Q2 2023

Aug 14, 2023
SELL
$21.44 - $25.15 $181,489 - $212,894
-8,465 Reduced 8.92%
86,483 $1.92 Million
Q1 2023

May 17, 2023
SELL
$19.2 - $24.47 $63,878 - $81,411
-3,327 Reduced 3.39%
94,948 $2.06 Million
Q4 2022

Feb 08, 2023
SELL
$19.95 - $29.96 $5,226 - $7,849
-262 Reduced 0.27%
98,275 $2 Million
Q3 2022

Nov 14, 2022
BUY
$24.7 - $29.12 $113,323 - $133,602
4,588 Added 4.88%
98,537 $2.53 Million
Q2 2022

Aug 16, 2022
BUY
$17.33 - $25.3 $283,085 - $413,275
16,335 Added 21.05%
93,949 $2.23 Million
Q1 2022

May 13, 2022
BUY
$16.53 - $25.21 $6,248 - $9,529
378 Added 0.49%
77,614 $1.75 Million
Q4 2021

Feb 16, 2022
SELL
$17.1 - $23.34 $121,375 - $165,667
-7,098 Reduced 8.42%
77,236 $1.53 Million
Q3 2021

Nov 15, 2021
SELL
$19.68 - $22.53 $29,067 - $33,276
-1,477 Reduced 1.72%
84,334 $1.66 Million
Q2 2021

Aug 19, 2021
SELL
$19.97 - $24.43 $18,372 - $22,475
-920 Reduced 1.06%
85,811 $1.89 Million
Q1 2021

May 17, 2021
BUY
$23.49 - $30.56 $4,416 - $5,745
188 Added 0.22%
86,731 $2.06 Million
Q4 2020

Feb 16, 2021
BUY
$16.78 - $27.3 $5,134 - $8,353
306 Added 0.35%
86,543 $2.26 Million
Q3 2020

Nov 10, 2020
SELL
$12.46 - $19.98 $1,183 - $1,898
-95 Reduced 0.11%
86,237 $1.5 Million
Q2 2020

Aug 12, 2020
BUY
$11.0 - $18.26 $1,452 - $2,410
132 Added 0.15%
86,332 $1.45 Million
Q1 2020

May 15, 2020
BUY
$10.11 - $14.04 $43,503 - $60,414
4,303 Added 5.25%
86,200 $1.03 Million
Q4 2019

Feb 13, 2020
BUY
$12.06 - $16.96 $7,211 - $10,142
598 Added 0.74%
81,897 $991,000
Q3 2019

Nov 14, 2019
SELL
$10.41 - $14.66 $6,277 - $8,839
-603 Reduced 0.74%
81,299 $1.15 Million
Q2 2019

Aug 13, 2019
BUY
$9.78 - $12.76 $15,804 - $20,620
1,616 Added 2.01%
81,902 $913,000
Q1 2019

May 14, 2019
BUY
$10.03 - $15.71 $66,448 - $104,078
6,625 Added 8.99%
80,286 $943,000
Q4 2018

Feb 15, 2019
BUY
$11.29 - $17.19 $18,289 - $27,847
1,620 Added 2.25%
73,661 $984,000
Q3 2018

Nov 15, 2018
BUY
$12.27 - $15.65 $78,883 - $100,613
6,429 Added 9.8%
72,041 $1.01 Million
Q2 2018

Aug 14, 2018
BUY
$15.3 - $19.69 $21,159 - $27,231
1,383 Added 2.15%
65,612 $1.03 Million
Q1 2018

May 08, 2018
BUY
$14.59 - $25.5 $104,551 - $182,733
7,166 Added 12.56%
64,229 $1.06 Million
Q4 2017

Feb 14, 2018
BUY
$15.77 - $20.72 $899,883 - $1.18 Million
57,063
57,063 $1.03 Million

Others Institutions Holding CORT

# of Institutions
470
Shares Held
83.2M
Call Options Held
489K
Put Options Held
1.02M
View Full List

About CORCEPT THERAPEUTICS INC

CORT Quotes by TradingView
  • Ticker CORT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,105,000
  • Market Cap $8.51B
  • Description
  • Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...
More about CORT
Track This Portfolio

Track Thrivent Financial For Lutherans Portfolio

Follow Thrivent Financial For Lutherans and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Thrivent Financial For Lutherans, based on Form 13F filings with the SEC.

News

Stay updated on Thrivent Financial For Lutherans with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email